$TRWA don’t fade the royal families https://t.co/XfUGeFIhLBJohnny (@CryptoGodJohn):$TWRA one thing I don’t fade is the royal families on the UAEMy biggest RWA bag looks ready to blast off https://t.co/X28Zpc0KVq ...

Which RWA altcoin are you most bullish on for Altseason?$LINK or $ONDO https://t.co/rjkA71s9lz ...

智通财经APP获悉，鉴于一项新的美国法律为稳定币确立了有史以来第一个监管规则，从华尔街金融巨 头美国银行(BAC.US)到美国中小型商业银行Fiserv(FI.US)等金融公司正准备推出其各自的基于美元支持 的"链上金融"体系，但有数字资产专家警告称，稳定币以及"链上金融"的未来之路可能并不简单。 《天才法案》(即GENIUS法案)为稳定币制定联邦规则，美国总统唐纳德·特朗普于7月18日签署《天才 法案》使之正式成为法律，为与美元挂钩、被称为"稳定币"的加密货币代币设定了联邦规则和官方指导 方针。这项旨在促进加密货币等数字资产使用规模的首部美国法律，可能为数字资产成为日常支付与跨 境转移资金的方式铺平道路。 稳定币旨在维持货币恒定价值，通常为与美元1:1挂钩。近年来，稳定币的使用激增，尤其是在加密交 易者在比特币与以太币等其他代币之间进出资金时，以及在跨境金融服务方面的渗透率加速增长。 稳定币也是一种特殊类型的加密货币，通过锚定美元、欧元、黄金等核心储备资产来维持稳定价值比 例。随着制定稳定币监管框架的关键立法在美国国会加速推进完成，这类维系价格稳定的加密货币开始 步入全球金融市场的主流资产领域。 稳定币的本 ...

（编辑 袁冠琳） 证券日报网讯 8月12日有投资者在互动平台向天阳科技提问"香港金管局推动'商业数据通'（CDI）促进 贸易融资，而RWA可提升应收账款、仓单等资产的流动性。公司此前为多家银行提供供应链金融系 统，是否已探索基于RWA的跨境贸易融资解决方案？例如通过智能合约实现自动结算？"公司回复"公 司目前暂无相应的解决方案。智能合约是跨境贸易融资的有效方案，公司的供应链金融解决方案处于市 场领先地位，会对此保持密切的关注"。 ...

Core Viewpoint - The article discusses the recent developments regarding Fosun International's application for a stablecoin license in Hong Kong, which has significantly impacted its stock price, alongside regulatory actions against former directors of Wanma Holdings [7][10][12]. Group 1: Fosun International and Stablecoin License - Fosun International's stock surged by up to 27.53% following news of its confirmed application for a stablecoin license in Hong Kong, closing at HKD 6.05 per share, a 13.30% increase [8][10]. - The founder of Fosun, Guo Guangchang, has shown a strong personal interest in the stablecoin license application, leading a team to meet with various Hong Kong officials [10]. - The Hong Kong Monetary Authority (HKMA) has recently implemented regulations for stablecoin issuers, indicating that only a few licenses will be granted initially, and cautioning against market exuberance [10][11]. Group 2: Wanma Holdings Regulatory Actions - The Hong Kong Stock Exchange and the Securities and Futures Commission have taken disciplinary actions against two former directors of Wanma Holdings for failing to cooperate with investigations [12][13]. - The actions include public reprimands and a determination that the former directors are unfit to hold any director or senior management positions within Wanma Holdings or its subsidiaries [13][14]. - The ongoing investigation by the Securities and Futures Commission highlights the importance of compliance and the serious consequences of neglecting responsibilities [15]. Group 3: China Unicom's Financial Performance - China Unicom reported a revenue exceeding RMB 200 billion for the first half of the year, reflecting a year-on-year growth of 1.5% [18][19]. - The company's pre-tax profit reached RMB 17.8 billion, marking a 5.1% increase compared to the previous year, and it announced an interim dividend of RMB 0.2841 per share, up 14.5% year-on-year [19].

Core Viewpoint - The recent surge in the stock price of Huajian Medical (01931.HK) is attributed to its innovative strategic initiatives, particularly the establishment of an Ethereum reserve and the launch of a new trading platform for tokenizing medical assets, which has garnered significant investor interest and market recognition [1][2][18]. Group 1: Company Strategy and Market Performance - Huajian Medical's stock price increased approximately 120% in July and over 91% in August, leading to a market capitalization exceeding HKD 15 billion [1]. - The company announced a strategic initiative to create an Ethereum reserve and a trading platform (ivd.xyz) aimed at tokenizing medical assets, which is expected to enhance its valuation and growth potential [1][2][10]. - The company has already purchased 5,190 Ethereum at a cost basis of USD 3,661 each, realizing a profit of approximately USD 330,000 as Ethereum's price surpassed USD 4,300 [1][2]. Group 2: Investment Perspective - Huajian Medical is positioned as a unique investment opportunity in the Hong Kong market, combining elements of cryptocurrency, healthcare, and Real World Assets (RWA) [2][10]. - The Ethereum reserve strategy is expected to provide a solid value foundation for the company's future growth, as Ethereum has seen a cumulative increase of over 70% since July [2][4]. - The company’s approach to continuously invest in Ethereum through a dollar-cost averaging strategy may lead to further valuation premiums as the cryptocurrency market evolves [7][8]. Group 3: RWA and Tokenization - RWA refers to the tokenization of real-world assets, allowing for digital representation and trading of various tangible and intangible assets on blockchain networks [10][13]. - Huajian Medical's initiative to tokenize innovative drug assets aims to enhance liquidity and broaden financing channels, making it easier for investors to participate in the medical innovation sector [14][15]. - The company's trading platform is designed to convert intellectual property related to innovative drugs into tradable tokens, addressing traditional financing challenges in the healthcare industry [15][16]. Group 4: Industry Implications - The strategic moves by Huajian Medical could potentially transform the medical industry by promoting digitalization and asset securitization, thereby accelerating the drug development process and improving overall industry efficiency [15][17]. - Collaborations with industry leaders, such as HashKey Group and BGI, are expected to enhance the management of Ethereum reserves and support the establishment of a tokenized fund for innovative drug intellectual property [16][17]. - The company's innovative model may set a new benchmark in the Hong Kong market, attracting more international investment into domestic innovative drug development [9][18].

Group 1 - The core viewpoint of the article highlights that Feiyang Group (01901) has seen a significant stock price increase of over 20%, currently trading at 0.415 HKD with a transaction volume of 9.4952 million HKD [1] - Feiyang Group announced a subscription agreement to issue a total of 166.4 million new shares at a subscription price of approximately 0.201 HKD per share, representing a discount of about 19.6% compared to the closing price of 0.250 HKD on the date of the agreement [1] - The net proceeds from the subscription, estimated at around 33 million HKD, are intended for the development and operation of emerging technology projects related to RWA (Real World Assets), digital asset trading, blockchain, and artificial intelligence, as well as general operational funds [1] Group 2 - Recently, Feiyang Group was invited to attend the "RWA Global Industry Alliance Launch Conference" held at Hong Kong Cyberport, where it explored the digitalization of cultural and tourism assets [1] - During the forum, Feiyang Group shared its core framework for digital exploration in the cultural and tourism industry, termed the "Three Rights Integration" model [1] - The strategic investor of Feiyang Group, Li Jieming, stated that through digital means, users participating in specific tourism products can simultaneously obtain threefold rights, creating real value for users and providing a feasible path for the digital transformation of the cultural and tourism industry, showcasing new business formats in the sector [1]

三大指数再创年内新高，芯片股集体爆发。电影电视概念股吉视传媒实现4连板，一图看懂>> 8月12日 新浪 强势 龙头 吉视传媒 A + 国产芯片 AI芯片龙头股价创新 路、工业互联网等中 海立股份 5天4板 公司为上海 却系统配套 756.71% 万通发展 3天3板 公司拟投资 注入优质芯 扬帆新材 公司是全球 的部分光引 ロイイロ \ | H!!ロ, 刀 元/公斤，化 累计涨幅近 上海合晶 公司主要产 功率器件和 凯美特气 子公司凯美 ASML子公 寒武纪 国内稀缺的 液冷服务器 ^ I ギャー ホ ㄷ ∧ I UPEII AI¶ホボン´|`/ 大元泵业 2天2板 公司表示已 品储备，已 为、中兴在 新朋股份 公司液冷服 户，表示未 决方案，将 控系统等集 冷散热所需 宏盛股份 公司主营业 相关产品的 备液冷产品 新疆機念 国铁集团950亿成立 洪通燃气 6天5板 新疆天然气 新疆交建 3天3板 实控人新疆 资质等级最 路工程施工 新疆火炬 3天3板 喀什天然气 疏附县的燃 钢铁 3天3板 / \ - 中国富武钢 > | Z 北新路桥 3天3板 西藏天昶建 子公司，主 程施工总承 必得科技 2天2板 轨道交通 ...

Core Viewpoint - 华检医疗 has experienced a significant stock price increase, with a cumulative rise of over 500% since July 14, 2023, and a current trading price of 11.95 HKD [1] Group 1: Strategic Developments - On August 8, 2023, 华检医疗 announced the launch of its "Global Enhanced Ethereum (ETH) Treasury" strategy and established a global strategic partnership with HashKey Group [1] - A signing ceremony for the global strategic cooperation and the upgrade of the Global Enhanced Ethereum (ETH) Treasury strategy was held on August 11, 2023, at HashKey's office in Hong Kong [1] Group 2: Collaborations and Investments - On July 30, 2023, 华检医疗 signed a strategic cooperation framework agreement with 华大共赢 to jointly establish the "华检华大共赢 Innovative Drug Intellectual Property Tokenization Fund" [1] - The fund aims to invest in 华检医疗's "NewCo+RWA" Web3 trading ecosystem projects in Hong Kong, the United States, and other locations [1] - 华大共赢, initiated by the biotechnology leader 华大基因, has extensive experience and resources in the fields of innovative medicine and drug investment [1]

Core Viewpoint - Huajian Medical (01931) has seen a significant stock price increase, with a cumulative rise of over 500% since July 14, and a current price of 11.95 HKD, reflecting a 19.5% increase at the time of reporting [1] Group 1: Strategic Developments - On August 8, Huajian Medical announced the launch of its "Global Enhanced Ethereum (ETH) Treasury" strategy and formed a global strategic partnership with HashKey Group [1] - A signing ceremony for the global strategic cooperation and the upgrade of the Global Enhanced Ethereum (ETH) Treasury strategy was held on August 11 at HashKey's office in Hong Kong [1] Group 2: Collaborations and Investments - On July 30, Huajian Medical signed a strategic cooperation framework agreement with BGI Win to establish the "Huajian BGI Win Innovative Drug Intellectual Property Tokenization Fund" [1] - This fund aims to invest in Huajian Medical's "NewCo+RWA" Web3 exchange ecosystem projects in Hong Kong, the United States, and other locations [1] - BGI Win, initiated by BGI Genomics, is a corporate venture capital entity with extensive experience and resources in innovative medical and pharmaceutical investments [1]